LFG Wealth Partners LLC Invests $1.75 Million in Agilent Technologies, Inc. $A

Key Points

• LFG Wealth Partners purchased 13,176 Agilent Technologies shares worth approximately $1.75 million during the second quarter, while several other institutional investors also increased their positions.
• Agilent reported quarterly EPS of $1.49, beating estimates of $1.41, while revenue rose 10% year over year to $1.83 billion. The company maintained fiscal 2026 EPS guidance of $6.00–$6.10.
• Analyst sentiment remains positive, with a consensus “Moderate Buy” rating and an average price target of $160.24; the company also pays a quarterly dividend of $0.255, yielding about 0.7% annually.

LFG Wealth Partners LLC purchased a new position in Agilent Technologies, Inc. (NYSE:A - Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 13,176 shares of the medical research company's stock, valued at approximately $1,750,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in Agilent Technologies by 4.3% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company's stock worth $82,712,000 after purchasing an additional 24,687 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its stake in Agilent Technologies by 20.9% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 53,422 shares of the medical research company's stock valued at $7,269,000 after purchasing an additional 9,236 shares during the last quarter. Dudley & Shanley Inc. increased its stake in Agilent Technologies by 25.9% during the second quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company's stock valued at $9,232,000 after purchasing an additional 14,300 shares during the last quarter. Crossmark Global Holdings Inc. raised its holdings in shares of Agilent Technologies by 39.6% during the fourth quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company's stock worth $4,615,000 after purchasing an additional 9,615 shares during the period. Finally, Capricorn Fund Managers Ltd acquired a new stake in shares of Agilent Technologies during the first quarter worth $8,161,000.

Agilent Technologies Trading Down 0.5%

Shares of NYSE:A opened at $148.55 on Friday. The company has a market cap of $41.95 billion, a PE ratio of 29.83, a P/E/G ratio of 2.63 and a beta of 1.25. The company's 50-day moving average price is $135.38 and its 200 day moving average price is $125.56. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A - Get Free Report) last posted its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm had revenue of $1.83 billion during the quarter, compared to analysts' expectations of $1.80 billion. During the same quarter in the prior year, the firm earned $1.31 EPS. Agilent Technologies's quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts anticipate that Agilent Technologies, Inc. will post 6.03 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th were issued a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, June 30th. Agilent Technologies's dividend payout ratio is 20.48%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on A. Morgan Stanley lifted their price target on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an "overweight" rating in a report on Wednesday. Barclays increased their price objective on shares of Agilent Technologies from $145.00 to $150.00 and gave the stock an "overweight" rating in a research note on Wednesday, June 24th. Sanford C. Bernstein started coverage on shares of Agilent Technologies in a report on Friday, June 26th. They issued an "outperform" rating and a $155.00 target price on the stock. Weiss Ratings upgraded Agilent Technologies from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, June 2nd. Finally, Jefferies Financial Group initiated coverage on Agilent Technologies in a report on Thursday, July 9th. They set a "hold" rating and a $135.00 target price for the company. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $160.24.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source